ScholarIQanswers from OpenAlex

Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial

PaperCitations, authors & open-access status

Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial have?

ScholarIQcitation count

Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial has 1 citations in the OpenAlex counts ScholarIQ stores.

When was Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial published?

ScholarIQyear

Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial has 2025 year in the ScholarIQ index.

What is the open-access status of Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial?

ScholarIQoa status

Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial has gold oa status in the ScholarIQ index.

What is the DOI of Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial?

ScholarIQdoi

The DOI for Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial is on the source record.

What is the PMID of Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial?

ScholarIQpmid

The PMID for Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial is on the source record.

What is the OpenAlex record for Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial?

ScholarIQopenalex

The OpenAlex for Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial